Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where remedy choices remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/cantor-fitzgerald-partners-with-anchorage-digital-and-copper-for-bitcoin-financing/